Results 241 to 250 of about 28,620 (278)

A phase I study of S-1 and cisplatin with concurrent hypofractionated carbon-ion radiotherapy for patients with stage III non-small cell lung cancer. [PDF]

open access: yesFront Oncol
Miura Y   +9 more
europepmc   +1 more source

Impact of perineural tumor spread in head and neck adenoid cystic carcinoma for carbon-ion radiotherapy. [PDF]

open access: yesClin Transl Radiat Oncol
Musha A   +11 more
europepmc   +1 more source

Clinical indications and future directions of carbon-ion radiotherapy: a narrative review. [PDF]

open access: yesEwha Med J
Choi SH   +8 more
europepmc   +1 more source

Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer. [PDF]

open access: yesNPJ Precis Oncol
Sishc BJ   +13 more
europepmc   +1 more source

Size-Sorted Superheated Nanodroplets for Dosimetry and Range Verification of Carbon-Ion Radiotherapy. [PDF]

open access: yesNanomaterials (Basel)
Toumia Y   +7 more
europepmc   +1 more source

Current Status of Carbon Ion Radiotherapy

open access: yesCurrent Status of Carbon Ion Radiotherapy
openaire  

Clinical Indications for Carbon Ion Radiotherapy

Clinical Oncology, 2018
Compared with photon and proton therapy, carbon ion radiotherapy (CIRT) offers potentially superior dose distributions, which may permit dose escalation with the potential for improved sparing of adjacent normal tissues. CIRT has increased biological effectiveness leading to increased tumour killing compared with other radiation modalities.
Mohamad, O., Yamada, S., Durante, M.
openaire   +3 more sources

Home - About - Disclaimer - Privacy